Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 12
238
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Isolation of cytotoxic sesquiterpene lactones from the Tanacetopsis karataviensis (Kovalevsk.) Kovalevsk

, ORCID Icon, , , , , , , & show all
Pages 1939-1948 | Received 01 Feb 2019, Accepted 18 Jul 2019, Published online: 30 Jul 2019
 

Abstract

The structures and anticancer effects of two sesquiterpene lactones, 1 R,10S,3S,4R-diepoxyguai-5S,6S,7S-11(13)-en-6,12-olide (1) and hanphyllin (2) isolated from the aerial part of Tanacetopsis karataviensis (Kovalevsk.) Kovalevsk were investigated. The compound 1 was isolated for the first time as a natural compound and its structure was investigated by HR-ESI-MS, IR and NMR techniques. The X-ray diffraction analysis was performed to accurately determine the spatial structures of 1 and 2. Furthermore, we evaluated the cytotoxic activity of 1 and 2, and the chloroform fraction which contains both of them. Cytotoxic activity revealed that the effect of the chloroform fraction is stronger in growth inhibition of HeLa (89.7%) and HEp-2 (63.0%) cancer cells than the effect of individual compounds 1 (55.9 and 36.3%), 2 (78.6 and 50.3%) and the reference cisplatin (58.0 and 46.8%) respectively. Moreover, the chloroform fraction is less toxic to the hepatocytes.

GRAPHICAL ABSTRACT

Acknowledgments

The authors wish to express their gratitude to Nabiyev U.O., an employee of the Institute of Bioorganic Chemistry of the Academy of Sciences of the Republic of Uzbekistan, for recording the HR-ESI-MS spectrum.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Program for Fundamental Scientific Research of the Uzbekistan Academy of Sciences under Grants TA-FA-F7-008 and VA-FA-F6-010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.